1,4-naphthoquinone has been researched along with paclitaxel in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, S; Foster, C; Kingston, DG; Lazo, JS; Murphy, BT | 1 |
| Abdeen, S; Chapman, E; Chitre, S; Hoang, QQ; Johnson, SM; Park, Y; Ray, AM; Salim, N; Sivinski, J; Stevens, M; Washburn, A | 1 |
2 other study(ies) available for 1,4-naphthoquinone and paclitaxel
| Article | Year |
|---|---|
Bioactivities of simplified adociaquinone B and naphthoquinone derivatives against Cdc25B, MKP-1, and MKP-3 phosphatases.
Topics: cdc25 Phosphatases; Cell Line, Tumor; Cell Proliferation; Cyclic S-Oxides; Dual Specificity Phosphatase 1; Dual Specificity Phosphatase 6; Enzyme Inhibitors; Humans; Magnetic Resonance Spectroscopy; Naphthoquinones; Spectrometry, Mass, Electrospray Ionization | 2009 |
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
Topics: Biological Products; Chaperonin 10; Chaperonin 60; Escherichia coli; Humans; Inhibitory Concentration 50; Protein Folding; Rafoxanide; Salicylanilides; Suramin | 2019 |